BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18829466)

  • 21. Insulin inhibits Na+/H+ exchange in vascular smooth muscle and endothelial cells in situ: involvement of H2O2 and tyrosine phosphatase SHP-2.
    Boedtkjer E; Aalkjaer C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H247-55. PubMed ID: 19036852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
    Xie ZH; Zhang J; Siraganian RP
    J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine phosphatase SHP-2 is a regulator of p27(Kip1) tyrosine phosphorylation.
    Tossidou I; Dangers M; Koch A; Brandt DT; Schiffer M; Kardinal C
    Cell Cycle; 2008 Dec; 7(24):3858-68. PubMed ID: 19066472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Src homology 2-containing protein tyrosine phosphatase-2 acts as a negative regulator for MUC5AC transcription via the inhibition of the ERK1/2 MAPK signalling pathway in the airway.
    Song KS; Choi JK; Ahn DW
    Acta Physiol (Oxf); 2013 Jul; 208(3):245-50. PubMed ID: 23582017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.
    Wu TR; Hong YK; Wang XD; Ling MY; Dragoi AM; Chung AS; Campbell AG; Han ZY; Feng GS; Chin YE
    J Biol Chem; 2002 Dec; 277(49):47572-80. PubMed ID: 12270932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.
    Zhan Y; Counelis GJ; O'Rourke DM
    Exp Cell Res; 2009 Aug; 315(14):2343-57. PubMed ID: 19427850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHP-2 phosphatase activity is required for PECAM-1-dependent cell motility.
    Zhu JX; Cao G; Williams JT; Delisser HM
    Am J Physiol Cell Physiol; 2010 Oct; 299(4):C854-65. PubMed ID: 20631249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
    Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
    Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway.
    Won KJ; Lee HM; Lee CK; Lin HY; Na H; Lim KW; Roh HY; Sim S; Song H; Choi WS; Lee SH; Kim B
    J Pharmacol Sci; 2011; 115(2):164-75. PubMed ID: 21343667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
    Walter AO; Peng ZY; Cartwright CA
    Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.
    Amin AR; Thakur VS; Paul RK; Feng GS; Qu CK; Mukhtar H; Agarwal ML
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5419-24. PubMed ID: 17369354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human TERT C-terminal polypeptide sensitizes HeLa cells to H2O2-induced senescence without affecting telomerase enzymatic activity.
    Huang J; Bai YX; Han SW; Ng SS; Jing DD; Wong BC; Huang CF; Kung HF; Lin MC
    Biochem Biophys Res Commun; 2003 Feb; 301(3):627-32. PubMed ID: 12565825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eIF4E-Overexpression imparts perillyl alcohol and rapamycin-mediated regulation of telomerase reverse transcriptase.
    Sundin T; Peffley D; Hentosh P
    Exp Cell Res; 2013 Aug; 319(13):2103-2112. PubMed ID: 23747720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability.
    Zhang P; Chan SL; Fu W; Mendoza M; Mattson MP
    FASEB J; 2003 Apr; 17(6):767-9. PubMed ID: 12594176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.
    Liu Y; Kruhlak MJ; Hao JJ; Shaw S
    J Leukoc Biol; 2007 Sep; 82(3):742-51. PubMed ID: 17575265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of tyrosine 568 controls nuclear export of Nrf2.
    Jain AK; Jaiswal AK
    J Biol Chem; 2006 Apr; 281(17):12132-42. PubMed ID: 16513647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant.
    Inagaki K; Noguchi T; Matozaki T; Horikawa T; Fukunaga K; Tsuda M; Ichihashi M; Kasuga M
    Oncogene; 2000 Jan; 19(1):75-84. PubMed ID: 10644982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHP-2 inhibits tyrosine phosphorylation of Cas-L and regulates cell migration.
    Yo K; Iwata S; Hashizume Y; Kondo S; Nomura S; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
    Biochem Biophys Res Commun; 2009 Apr; 382(1):210-4. PubMed ID: 19275884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.